Autism: Gauging two protein levels may help in early diagnosis
Autism: Gauging two protein levels may help in early diagnosis
The Results, Guided By Researchers From The University Of Texas Southwestern Medical Centre, Revealed That Gauging The Levels Of Proteins, Namely Thyroid-stimulating Hormone (TSH) And Interleukin-8 (IL-8) Alone Would Vary From 74 To 76 Per Cent.
News Nation Bureau | Edited By : Bindiya Bhatt | Updated on: 03 Jul 2017, 04:31:54 PM
New Delhi:
Autism is a neuro-developmental disorder whose typical features are social interaction and communication challenges, and limited and repetitive patterns of behaviour. The results, guided by researchers from the University of Texas Southwestern Medical Centre, revealed that gauging the levels of proteins, namely thyroid-stimulating hormone (TSH) and interleukin-8 (IL-8) alone would vary from 74 to 76 per cent.
Dallas County is reporting 1,407 new COVID-19 cases Saturday along with 20 more deaths related to the virus, capping the deadliest week in the county since the.
E-Mail
New research from the University of Iowa and University Hospitals Cleveland Medical Center demonstrates that offspring can be protected from the effects of prenatal stress by administering a neuroprotective compound during pregnancy.
Working in a mouse model, Rachel Schroeder, a student in the UI Interdisciplinary Graduate Program in Neuroscience, drew a connection between the work of her two mentors, Hanna Stevens, MD, PhD, UI associate professor of psychiatry and Ida P. Haller Chair of Child and Adolescent Psychiatry, and Andrew A. Pieper, MD, PhD, a former UI faculty member, now Morley-Mather Chair of Neuropsychiatry at Case Western Reserve University and Investigator and Director of the Neurotherapeutics Center at the Harrington Discovery Institute, University Hospitals Cleveland Medical Center.
Ludwig Cancer Research Study Reveals How Certain Gut Bacteria Compromise Radiotherapy
Ludwig Chicago Co-director Ralph Weichselbaum and Kaiting Yang, a postdoctoral researcher in Weichselbaum s lab. Image courtesy of Ludwig Cancer Research
January 28, 2021 A study led by Ludwig Chicago Co-director Ralph Weichselbaum, M.D., and Yang-Xin Fu, M.D., Ph.D., of the University of Texas Southwestern Medical Center has shown how bacteria in the gut can dull the efficacy of radiotherapy, a treatment received by about half of all cancer patients. Their findings appear in the current issue of the Our study identifies two families of gut bacteria that interfere with radiotherapy in mice and describes the mechanism by which a metabolite they produce a short chain fatty acid called butyrate undermines the therapy, said Weichselbaum.
Date Time
Ludwig Cancer Research study reveals how certain gut bacteria compromise radiotherapy
A study led by Ludwig Chicago Co-director Ralph Weichselbaum and Yang-Xin Fu of the University of Texas Southwestern Medical Center has shown how bacteria in the gut can dull the efficacy of radiotherapy, a treatment received by about half of all cancer patients. Their findings appear in the current issue of the Journal of Experimental Medicine.
“Our study identifies two families of gut bacteria that interfere with radiotherapy in mice and describes the mechanism by which a metabolite they produce-a short chain fatty acid called butyrate-undermines the therapy,” said Weichselbaum.